Notice of Withdrawal: No Incidence of Nephrogenic Systemic Fibrosis after Gadobenate Dimeglumine Administration in Patients Undergoing Dialysis or Those with Severe Chronic Kidney Disease

Radiology. 2018 Jan;286(1):113-119. doi: 10.1148/radiol.2017170102. Epub 2017 Jul 21.

Abstract

The authors have requested to withdraw this manuscript from publication because the study was not conducted in full accordance with the relevant institutional IRB protocol. © RSNA, 2018.

Publication types

  • Retracted Publication

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Contrast Media / adverse effects*
  • Contrast Media / therapeutic use
  • Female
  • Humans
  • Magnetic Resonance Imaging* / adverse effects
  • Magnetic Resonance Imaging* / methods
  • Magnetic Resonance Imaging* / statistics & numerical data
  • Male
  • Meglumine / adverse effects
  • Meglumine / analogs & derivatives*
  • Meglumine / therapeutic use
  • Middle Aged
  • Nephrogenic Fibrosing Dermopathy* / chemically induced
  • Nephrogenic Fibrosing Dermopathy* / epidemiology
  • Organometallic Compounds / adverse effects*
  • Organometallic Compounds / therapeutic use
  • Renal Dialysis / statistics & numerical data*
  • Renal Insufficiency, Chronic / diagnostic imaging
  • Renal Insufficiency, Chronic / therapy*
  • Retrospective Studies
  • Young Adult

Substances

  • Contrast Media
  • Organometallic Compounds
  • gadobenic acid
  • Meglumine